Scott L Burrows - Net Worth and Insider Trading

Scott L Burrows Net Worth

The estimated net worth of Scott L Burrows is at least $9 Million dollars as of 2026-09-06. Scott L Burrows is the CFO of Spyre Therapeutics Inc and owns about 79,762 shares of Spyre Therapeutics Inc (SYRE) stock worth over $7 Million. Scott L Burrows is also the CFO of Arcutis Biotherapeutics Inc and owns about 59,115 shares of Arcutis Biotherapeutics Inc (ARQT) stock worth over $1 Million. Details can be seen in Scott L Burrows's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Scott L Burrows has not made any transactions after 2026-09-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Scott L Burrows

To

Scott L Burrows Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Scott L Burrows owns 2 companies in total, including Arcutis Biotherapeutics Inc (ARQT) , and Spyre Therapeutics Inc (SYRE) .

Click here to see the complete history of Scott L Burrows’s form 4 insider trades.

Insider Ownership Summary of Scott L Burrows

Ticker Company Transaction Date Type of Owner
ARQT Arcutis Biotherapeutics Inc 2023-03-06 Chief Financial Officer
SYRE Spyre Therapeutics Inc 2026-09-02 Chief Financial Officer

Scott L Burrows Latest Holdings Summary

Scott L Burrows currently owns a total of 2 stocks. Among these stocks, Scott L Burrows owns 79,762 shares of Spyre Therapeutics Inc (SYRE) as of September 2, 2026, with a value of $7 Million and a weighting of 83.4%. Scott L Burrows also owns 59,115 shares of Arcutis Biotherapeutics Inc (ARQT) as of March 6, 2023, with a value of $1 Million and a weighting of 16.6%.

Latest Holdings of Scott L Burrows

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SYRE Spyre Therapeutics Inc 2026-09-02 79,762 88.98 7,097,223
ARQT Arcutis Biotherapeutics Inc 2023-03-06 59,115 23.89 1,412,257

Holding Weightings of Scott L Burrows


Scott L Burrows Form 4 Trading Tracker

According to the SEC Form 4 filings, Scott L Burrows has made a total of 10 transactions in Spyre Therapeutics Inc (SYRE) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Spyre Therapeutics Inc is the sale of 25,732 shares on September 2, 2026, which brought Scott L Burrows around $2 Million.

According to the SEC Form 4 filings, Scott L Burrows has made a total of 4 transactions in Arcutis Biotherapeutics Inc (ARQT) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Arcutis Biotherapeutics Inc is the sale of 291 shares on March 6, 2023, which brought Scott L Burrows around $4,441.

Insider Trading History of Scott L Burrows

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Scott L Burrows Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Scott L Burrows owns.
View SYRE Analysis

Scott L Burrows Ownership Network

Ownership Network List of Scott L Burrows

No Data

Ownership Network Relation of Scott L Burrows

Insider Network Chart


Scott L Burrows Owned Company Details

What does Arcutis Biotherapeutics Inc do?

Who are the key executives at Arcutis Biotherapeutics Inc?

Scott L Burrows is the Chief Financial Officer of Arcutis Biotherapeutics Inc. Other key executives at Arcutis Biotherapeutics Inc include See Remarks Patrick Burnett , director & President and CEO Todd Franklin Watanabe , and SVP and General Counsel Masaru Matsuda .

Arcutis Biotherapeutics Inc (ARQT) Insider Trades Summary

Over the past 18 months, Scott L Burrows made no insider transaction in Arcutis Biotherapeutics Inc (ARQT). Other recent insider transactions involving Arcutis Biotherapeutics Inc (ARQT) include a net sale of 185,015 shares made by Patrick Burnett , a net sale of 150,682 shares made by Howard G. Welgus , and a net sale of 249,271 shares made by Todd Franklin Watanabe .

In summary, during the past 3 months, insiders sold 81,666 shares of Arcutis Biotherapeutics Inc (ARQT) in total and bought 0 shares, with a net sale of 81,666 shares. During the past 18 months, 936,204 shares of Arcutis Biotherapeutics Inc (ARQT) were sold and 27,448 shares were bought by its insiders, resulting in a net sale of 908,756 shares.

Arcutis Biotherapeutics Inc (ARQT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arcutis Biotherapeutics Inc Insider Transactions

No Available Data

Scott L Burrows Mailing Address

Above is the net worth, insider trading, and ownership report for Scott L Burrows. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Scott L Burrows's mailing address is: Waltham Ma 02453.